Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

Exactly, patents of VIP extracted from animals. It is claimed by NRXP that AVIPTADIL (synthetic) generic was used to continue development of Zyesami (TM). Zyesami (tm) in acetate buffer vs RLF-100 in no buffer. Well, if the AVIPTADIL patent holder is RLFTF, what exactly did SUNY license to NRXP or does it matter? Is all this an NRXP stunt to negotiate terms with RLFTF, for further development of Zyesami (tm), all under the assumption they get approval for Zyesami (tm) IV?

Patent US8178489B2

Inventor Gerald BacherDorian Bevec Current Assignee Relief Therapeutics International Sa

https://patents.google.com/patent/US8178489B2/en

Mondobiotech Aviptadil, expired.

https://patents.google.com/patent/WO2006094764A1/en